Drug Pricing
Commentary
The New Senate’s Top Priority: Destroying Drug Innovation?
Minnesota Senator Amy Klobuchar just introduced a federal budget amendment that would legalize the importation of foreign prescription drugs. This particular policy change has long topped Democrats’ health care wish list, but shockingly, they might find support across the aisle this year, as President-elect Trump has spoken glowingly of importation. ...
Business & Economics
Addressing The Systemic Problems Of Rising Health Care Costs In America
Even with the 2016 Presidential campaign mercifully coming to an end, there is more drama to come. While there will be many epicenters, perhaps none will impact the daily lives of more citizens than the impending drama in the health care industry. While not referring to the Affordable Care Act, ...
California
Health Care Needs Effective Reforms, Not the CREATES Act
Congress is back in session. With the election looming, this means a frenetic dash to pass bills on a number of big ticket items, including the budget and Zika funding. While the legislative fight over these issues will likely dominate the headlines, we cannot forget about other below-the-radar, but nevertheless ...
Commentary
Need A Roadmap For Healthcare Reform? Look At Medicare Part D
Paul Ryan and his House Republican colleagues just released their much-anticipated plan to reform America’s healthcare system. Their 37-page proposal would, among other things, transform Medicare into a “premium support” program. Seniors would be able to use federal subsidies to buy their choice of health plans from private insurers, instead ...
California
The high price of “cheap” drugs
California is losing the battle against opioid addiction. Every 45 minutes, someone in the Golden State overdoses. Fifty percent more people overdose today than in 2006. Fortunately, the Food and Drug Administration just approved the anti-addiction treatment Probuphine. It’s an implant placed in a person’s upper arm, where it releases ...
Business & Economics
Who’s Afraid of Anti-Inversion Rules?
Swift and merciless. That was the apparent effect the U.S. Treasury’s April 4 regulatory package had on what was poised to be the largest inversion in history. But several pending inversions have emerged relatively unscathed, and experts are predicting continued corporate exodus, raising questions about what exactly Treasury has accomplished. ...
Commentary
Trump and Obama promise to be terrible negotiators
President Barack Obama and presidential hopeful Donald Trump don’t agree on much. But they’ve found common ground in pushing to upend the Medicare drug benefit. At a rally days before his resounding victory in New Hampshire, Trump grumbled about government drug spending — and called for Medicare to take over ...
Commentary
Hillary’s Price Controls Would Kill New Drug Innovation
Like your iPhone? Federal officials designed it. Couldn’t live without the Internet? Thank Uncle Sam — he invented it. Sick and need new medicine? Don’t worry — the government is here to help. This fantastical line of thinking — that because the government funded basic, early-stage research, it can claim ...
Commentary
To control drug prices, pursue fraud, not manufacturers
A Los Angeles-based nonprofit has gathered enough signatures to get two initiatives on the November ballot. The one of greater interest to ordinary Californians would legislate that any prescription drug paid for with state money cost no more than the amount paid by the Veterans Administration. The California Drug Price ...
Commentary
Clinton would drive up health care costs
Five years and nine months after its passage, the federal government has issued more than 10,000 pages of regulations related to the implementation of Obamacare. Get ready for several thousand more pages if Hillary Clinton takes the White House. She’s proposing a raft of new government mandates to “protect the ...
The New Senate’s Top Priority: Destroying Drug Innovation?
Minnesota Senator Amy Klobuchar just introduced a federal budget amendment that would legalize the importation of foreign prescription drugs. This particular policy change has long topped Democrats’ health care wish list, but shockingly, they might find support across the aisle this year, as President-elect Trump has spoken glowingly of importation. ...
Addressing The Systemic Problems Of Rising Health Care Costs In America
Even with the 2016 Presidential campaign mercifully coming to an end, there is more drama to come. While there will be many epicenters, perhaps none will impact the daily lives of more citizens than the impending drama in the health care industry. While not referring to the Affordable Care Act, ...
Health Care Needs Effective Reforms, Not the CREATES Act
Congress is back in session. With the election looming, this means a frenetic dash to pass bills on a number of big ticket items, including the budget and Zika funding. While the legislative fight over these issues will likely dominate the headlines, we cannot forget about other below-the-radar, but nevertheless ...
Need A Roadmap For Healthcare Reform? Look At Medicare Part D
Paul Ryan and his House Republican colleagues just released their much-anticipated plan to reform America’s healthcare system. Their 37-page proposal would, among other things, transform Medicare into a “premium support” program. Seniors would be able to use federal subsidies to buy their choice of health plans from private insurers, instead ...
The high price of “cheap” drugs
California is losing the battle against opioid addiction. Every 45 minutes, someone in the Golden State overdoses. Fifty percent more people overdose today than in 2006. Fortunately, the Food and Drug Administration just approved the anti-addiction treatment Probuphine. It’s an implant placed in a person’s upper arm, where it releases ...
Who’s Afraid of Anti-Inversion Rules?
Swift and merciless. That was the apparent effect the U.S. Treasury’s April 4 regulatory package had on what was poised to be the largest inversion in history. But several pending inversions have emerged relatively unscathed, and experts are predicting continued corporate exodus, raising questions about what exactly Treasury has accomplished. ...
Trump and Obama promise to be terrible negotiators
President Barack Obama and presidential hopeful Donald Trump don’t agree on much. But they’ve found common ground in pushing to upend the Medicare drug benefit. At a rally days before his resounding victory in New Hampshire, Trump grumbled about government drug spending — and called for Medicare to take over ...
Hillary’s Price Controls Would Kill New Drug Innovation
Like your iPhone? Federal officials designed it. Couldn’t live without the Internet? Thank Uncle Sam — he invented it. Sick and need new medicine? Don’t worry — the government is here to help. This fantastical line of thinking — that because the government funded basic, early-stage research, it can claim ...
To control drug prices, pursue fraud, not manufacturers
A Los Angeles-based nonprofit has gathered enough signatures to get two initiatives on the November ballot. The one of greater interest to ordinary Californians would legislate that any prescription drug paid for with state money cost no more than the amount paid by the Veterans Administration. The California Drug Price ...
Clinton would drive up health care costs
Five years and nine months after its passage, the federal government has issued more than 10,000 pages of regulations related to the implementation of Obamacare. Get ready for several thousand more pages if Hillary Clinton takes the White House. She’s proposing a raft of new government mandates to “protect the ...
